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Salmonella Degrades the Host 
Glycocalyx Leading to Altered 
Infection and Glycan Remodeling
Narine Arabyan1, Dayoung Park2, Soraya Foutouhi1, Allison M. Weis1, Bihua C. Huang1, 
Cynthia C. Williams2, Prerak Desai1,†, Jigna Shah1,‡, Richard Jeannotte1,3,§, Nguyet Kong1, 
Carlito B. Lebrilla2,4 & Bart C. Weimer1
Complex glycans cover the gut epithelial surface to protect the cell from the environment. Invasive 
pathogens must breach the glycan layer before initiating infection. While glycan degradation is crucial 
for infection, this process is inadequately understood. Salmonella contains 47 glycosyl hydrolases (GHs) 
that may degrade the glycan. We hypothesized that keystone genes from the entire GH complement 
of Salmonella are required to degrade glycans to change infection. This study determined that GHs 
recognize the terminal monosaccharides (N-acetylneuraminic acid (Neu5Ac), galactose, mannose, 
and fucose) and significantly (p < 0.05) alter infection. During infection, Salmonella used its two GHs 
sialidase nanH and amylase malS for internalization by targeting different glycan structures. The host 
glycans were altered during Salmonella association via the induction of N-glycan biosynthesis pathways 
leading to modification of host glycans by increasing fucosylation and mannose content, while 
decreasing sialylation. Gene expression analysis indicated that the host cell responded by regulating 
more than 50 genes resulting in remodeled glycans in response to Salmonella treatment. This study 
established the glycan structures on colonic epithelial cells, determined that Salmonella required two 
keystone GHs for internalization, and left remodeled host glycans as a result of infection. These data 
indicate that microbial GHs are undiscovered virulence factors.
Epithelial cells in the human gastrointestinal tract (GIT) are covered with at least two glycan layers, composed of 
multiple layers of glycoproteins (mucin) and complex oligosaccharides (glycocalyx) that protect cells from the 
local environment and infection1. Mucin is the most distal layer of glycoproteins in the GIT lumen and is directly 
exposed to the luminal microbiome. The glycocalyx layer is adjacent the epithelial membrane that is composed of 
trans-membrane glycoproteins and glycolipids and are components of membrane lipid rafts that extend from the 
membrane, which are specific bacterial and viral receptors used for microbial invasion resulting in transduction 
of extracellular signals into the cell2–5. Glycans represent the first and crucial interface of the cell surface through 
which microbes interact with the host immune system mediating recognition and communication processes; 
thus, controlling immunological recognition, cell-cell adhesion, and pathogen binding. Glycans are mixture of 
structures that include short chains of saccharides, with simple structures to highly branched complex oligosac-
charides that are complicated with an array of specific linkages between the monosaccharide residues leading to 
a large diversity in arrangements during their synthesis to form higher order chemical structures1. In the case of 
bacterial pathogens, this layer provides a barrier to physically exclude microorganisms from gaining access to 
the epithelial membrane and the associated receptors used for infection and have been suggested to be used for 
co-evolution with commensal bacteria2.
Bacterial interaction with the epithelial surface via the glycan has been recognized for many years with the 
use of lectins to identify microbial activity6. Beyond system level interactions specific interactions with via fucose 
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and sialic acid have been implicated to regulate commensal interactions and provide sugar sources in complex 
communities where some members may cleave the sugar for use by other community members6–10. The specific 
linkages (i.e. α -1,2/3/4 and α -2,3/6 linkages), in addition to these specific sugars are also implicated in controlling 
the microbial interaction11. The breath of the microbes that interact with mucin and the underlying glycocalyx 
interactions is large and has been suggested to be a primary underpinning of co-evolution of an individual and 
their microbiome11,12. In fact, recognition of the glycan as the primary interacting surface has also led to detailing 
the very large and complex carbohydrate digestion enzymes in bacteria that are assembled in CAZymes13. Use of 
the host glycan to provide nutrients that regulate bacterial infection and virulence is increasingly recognized as 
an important characteristic for individual microbes to penetrate the mucin layers and subsequently gain access to 
the cell membrane for association and invasion to progress into the disease state14,15.
Salmonella, and other invasive enteric pathogens, developed mechanisms to breach the protective glycan 
layers of host cells, which permits access to the host membrane receptors, that results in invasive intracellular 
infection. The diversity and complexity of the entire epithelial glycan barrier mandates that a breadth of enzy-
matic activities is required to degrade these diverse glycans to gain access of the cell membrane. Degradation of 
these compounds relies in part on glycosyl hydrolases (GHs). GHs are diverse, widely distributed in bacteria, 
yet poorly characterized enzymes, which hinder determining their specific role during infection dynamics16,17. 
To date there are no studies that define the specific role of the diverse GHs found in Salmonella during infec-
tion16,17. In this study, we hypothesized that only a portion of the 21 different GH families that encompass 49 
total carbohydrate-active enzymes in Salmonella may degrade glycans to gain access of the host membrane and 
the microbe receptors used for invasion. Eilam et al. demonstrated that microbe’s glycan degradation potential is 
associated with gut pathogens18. It was hypothesized in this study that unique and specific GHs in Salmonella are 
required for invasive infection.
Here, we conducted a detailed study of how Salmonella degrades the glycocalyx layer of human colonic epi-
thelial cells (Caco-2) during in vitro infection and led to host glycan remodeling. We established that two GHs, 
ΔnanH and ΔmalS, decrease invasion to non-invasive levels comparable to ΔinvA, suggesting that these GHs 
may be new virulence factors. The N-glycome of Caco-2 cells during infection was profiled and showed how 
Salmonella used its glycan-degrading enzymes, nanH and malS, to degrade the glycocalyx layer. More surpris-
ingly, we identified that the host cell responded to microbial glycan degradation by modifying its own glycans 
leading to decreased sialylation; however, increased fucosylation, higher-mannose, and more hybrid glycans. 
This alteration in host glycans was due to induction of N-glycan biosynthesis pathways during Salmonella associ-
ation. This study demonstrates that a complex molecular interplay between epithelial cells and pathogens result 
in altered association, but infection proceeds if bacteria have the appropriate GH compliment to overcome the 
dynamic changes in the glycan.
Results
Glycan Degrading Enzymes Alter Host Membrane Access during Invasion of Salmonella. To 
determine if glycans are involved during infection, we first investigated if the removal of Neu5Ac (the outermost 
monosaccharide on most N-glycans of animals) from Caco-2 cells affected Salmonella attachment. Caco-2 cells 
were exposed to sialidase digestion to remove terminal Neu5Ac. As a control, Caco-2 cells were also subjected to 
methyl-β -cyclodextrin (Mβ CD) treatment since Mβ CD inhibits caveolae-dependent endocytosis via disruption 
of lipid rafts19. Depletion of cell surface Neu5Ac led to a significant (p < 0.05) reduction in Salmonella association 
(Fig. 1A), further implicating the importance of Neu5Ac in the adherence process. To determine if genes related 
to metabolism of sugars released from glycan are involved during infection, nanT (STM3338; sialic acid trans-
porter), xylR (STM3662; xylose operon regulatory protein), and bax (STM3663; hypothetical protein similar to 
ATP-binding protein) were deleted using homologous recombination20, characterized in their capacity to infect, 
and for alteration in invasion in vitro with Caco-2 cells (Fig. 1B). Deletion of these genes did not significantly 
change association compared to Salmonella enterica subsp. enterica serovar Typhimurium strain LT2, suggesting 
that genes related to metabolism of sugars are not involved in additional invasion.
Deletion of each gene was verified using whole genome sequencing of the wild type and each deletion mutant 
(Supplementary Figure S1B and C). Reference based assembly and de novo assembly showed that the genomes 
were isogenic, that only the gene of interest was specifically replaced with the chloramphenicol resistance gene, 
and that the genome-to-genome distance was not significantly different (p > 0.001). Taken together, these data 
indicate that the gene deletions were adequate to delineate the multi-gene effect demonstrated in this work to 
digest complex glycans to gain access to the host membrane.
To further test the hypothesis if glycan-degrading GHs alter host membrane access during infection, we ana-
lyzed the gene expression of the annotated GHs of Salmonella Typhimurium LT2 during in vitro infection of 
Caco-2 cells (Supplementary Table S1). Knowing the most common terminal residues on glycans (i.e. Neu5Ac, 
galactose, and mannose), GHs that can cleave the most common residues and linkages, along with gene expres-
sion analysis, we identified that sialidases (STM0928 and STM1252), galactosidase (STM4298), and amylases 
(STM3664 and STM3537) likely play an important role during infection. To determine if these GHs are importand 
for infection, these GHs in Salmonella Typhimurium LT2 were also deleted (Supplementary Figure S1A) 
and used to characterize their ability to infect and alter invasion in vitro using differentiated (i.e. polarized) 
colonic epithelial cells (Caco-2 cells) (Fig. 1B). These enzymes targeted different glycans based on their termi-
nal sugar specificity, as seen with the differences in the infectivity of each bacterial mutant (Fig. 1B), further 
implicating terminal sugar digestion could be important during infection so that the T3SS can gain access to 
the membrane to initiate injection of effector molecules. α -Galactosidase (STM4298; melA) recognizes terminal 
α -galactose molecules of glycans. Deletion of melA led to a similar invasion phenotype as the WT.
Salmonella LT2 contains two sialidases in its genome: nanH (STM0928) and CHPNeu (STM1252; Conserved 
Hydrolase Putative Neuraminidase), both of which were deleted from the genome in this study. Genetic 
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comparison of these genes found that nanH has homology with genes from bacteria and parasites (Supplementary 
Figure S2A). Gene homology for CHPNeu was broadly distributed among bacteria from the gut and environment 
(Supplementary Figure S2B and S2C). In Salmonella there is very little DNA sequence homology between nanH 
and CHPNeu; however, the domain structures were conserved, which allowed identification of function between 
organisms to provide molecular markers to define two different neuraminidases in Salmonella that are enzymat-
ically, and likely play different roles different during infection (Supplementary Figure S3). Nitrogenases among 
microbial genomes also display wide sequence diversity, but retain conservation of enzymatically important 
domains21. Deletion of nanH significantly decreased invasion (p = 0.0059). The ΔCHPNeu mutant significantly 
increased invasion (p = 0.01).
The amylase genes (malS and glgX) are also divergent in their sequence, but both contain the required domains 
for amylase activity (Supplementary Figure S4). Deletion of malS (STM3664; α -amylase) significantly decreased 
Salmonella invasion (p < 0.0001), resulting in the same level of invasion as ΔinvA (STM2896; needle complex 
export protein for T3SS), which is considered non-pathogenic and deficient for adhesion and invasion in vivo22. 
Surprisingly, deletion of glgX (STM3537; glycogen debranching enzyme), which is an amylase-like enzyme with 
broader hexose specificity, led to a significant increase in invasion (p = 0.0002). Perhaps the deletion of CHPNeu 
and glgX affected other genes involved in virulence, such as the nanH and malS. The invasion levels of nanH and 
malS mutants were not significantly different (p > 0.05) compared to those found for ΔinvA; hence, nanH and 
malS may represent new virulence genes in Salmonella infections. These observations led to the hypothesis that 
Salmonella targets specific glycan structures during infection that enable the T3SS needle complex access to the 
membrane since it is not long enough to penetrate the glycan structures on epithelial cells.
Salmonella Infection Led to Alteration in Host N-Glycome. We initiated the glycan definition by 
determining the glycan structure and composition of uninfected Caco-2 cells to define the N-glycome baseline 
to allow comparison of the changes made by Salmonella during infection. This approach is of particular interest 
because it extends the specificity beyond binding via lectin-like activities and can be directly linked to enzyme 
Figure 1. Modulation of carbohydrate-degrading enzymes alter access during invasion of Salmonella WT. 
(A) Neu5Ac digestion. Methyl-β -cyclodextrin (control) disrupts lipid rafts. Sialidase treatment led to reduction 
in Salmonella association. Least Squares Means Differences (LSD) was used for statistical analysis. Levels 
not connected with the same letter are significantly different, p < 0.05. (B) Salmonella WT knockout strains 
characterized for the alteration in adhesion and invasion (A/I) using differentiated Caco-2 cells 60 minutes post-
infection. White bars represent the CFU of Salmonella WT that adhered per Caco-2 cell. The gray bars represent 
the CFU of Salmonella WT that invaded per Caco-2 cell. This was done in combination with transcriptional 
profiling (bottom panel) of Salmonella WT during infection of Caco-2 cells to gain insights about differentially 
expressed carbohydrate-degrading genes. Salmonella WT genes displaying changes in gene expression levels 
during infection of Caco-2 cells. Colors indicate the expression of each gene induced (red) and repressed 
(green). LSD was used for statistical analysis. Error bars indicate SEM between 3 biological replications,  
* p < 0.05, * * p < 0.001, * * * p < 0.0001, Not Significant (NS). The statistics shown at the top indicates the 
statistical relevance in invasion levels of ΔinvA compared to the mutant strains.
www.nature.com/scientificreports/
4Scientific RepoRts | 6:29525 | DOI: 10.1038/srep29525
activity and genes in Salmonella that are required to infect. The changes in host N-linked glycan profile are of par-
ticular interest as they comprise approximately 90% of the glycans present in eukaryotic cells and modification in 
these types of glycans has been linked to multiple diseases23, but no specific structure has been directly linked to 
infection even though specific sugars (i.e. sialic acid and fucose) are known to impact the microbiome and associ-
ation with the host. Uninfected Caco-2 cells contained 191 distinct glycan structures (Supplementary Figure S5A, 
Supplementary Table S2). The Caco-2 N-glycans were rich in mannose, galactose, N-acetylglucosamine, fucose, 
and N-acetylneuraminic acid (Neu5Ac). The relative abundance of specific structures changed significantly 
(p < 0.05) during Salmonella infection (Supplementary Figure S5B, Supplementary Table S2) when compared 
to uninfected cells (Supplementary Figure S5A, Supplementary Table S2). Within 60 minutes of Salmonella 
infection, the host glycome contained substantially different structures compared to uninfected Caco-2 cells 
(Supplementary Figure S5B) that led to 185 total glycan structures. During infection 13 glycans completely 
disappeared (Fig. 2D, Supplementary Table S2) and seven glycans were appeared on the host surface (Fig. 2F, 
Supplementary Table S2). There were also some glycans with intermediate abundance changes with decreases 
(Fig. 2A–C, Supplementary Table S2) while others increased (Fig. 2E, Supplementary Table S2), yet other glycans 
were similar to uninfected Caco-2 cells (Supplementary Table S2). Interestingly, the glycans resulting from infec-
tion were composed of high-mannose-containing structures and complex glycans that were polyfucosylated with 
the terminal branches containing up to five fucose molecules, while the majority of the glycans that disappeared 
were polysialylated.
Host Cells Modify Their Own Glycan during Microbial Glycan Degradation. Using gene expres-
sion and canonical pathway analysis we examined the host response during infection and glycan degradation. 
Significantly differentially (q < 0.05) regulated genes following Salmonella infection were marked by the induc-
tion of genes directly involved in glycan biosynthesis (Fig. 3A, Supplementary Table S3). All mannosidases and 
mannosyltransferases were all significantly induced (q < 0.05) (Fig. 3B) that was concomitantly observed in 
the accumulation of mannose in the glycan structures using mass spectrometry described above. The fucosi-
dase, FUCA2, and all seven fucosyltransferases were significantly induced (q < 0.05) (Fig. 3C) that, again was 
Figure 2. Host glycome is substantially altered during infection with Salmonella WT within 60 minutes. 
The bars represent the relative abundance levels of each significant glycan during infection with Salmonella.  
(A) Decrease in complex-fucosylated glycans; (B) Decrease in high-mannose and hybrid glycans; (C) Decrease 
in sialylated glycans; (D) Disappearance of sialylated glycans; (E) Accumulation of high-mannose and complex 
glycans; (F) New complex-fucosylated and sialylated glycans. Error bars indicate SEM between 3 biological 
replications, * p < 0.05, * * p < 0.001, * * * p < 0.0001.
www.nature.com/scientificreports/
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concomitantly observed in the increase in fucose at the terminal residue in the cellular glycan. The Salmonella 
genome does not contain fucosidases, so it is reasonable that these glycans accumulate via host production and 
modification.
The overall Neu5Ac content of the glycan was a result of removal by Salmonella. We observed induction of 
NEU1, NEU2, NEU3, and NEU4 in the host led us to presume that these genes were collectively responsible for 
additional modification of the glycan. The four exo-α -sialidases in the host, each of which has a different substrate 
specificity, were regulated independently with two induced and two unregulated, had median expression levels. 
NEU2 and NEU4 were not regulated during infection (Fig. 3D). NEU1, which is commonly located at the lyso-
some and NEU3, found on cell surfaces, were induced during infection (Fig. 3D). The two sialidases in Salmonella 
were induced during infection, suggesting that Neu5Ac would be released. The glycans were depleted in Neu5Ac 
during infection, which may indicate the cooperative activity of the host and the pathogen resulted in a reduction 
of the degree of sialylation from three to one (Fig. 4).
Glycan Degrading Enzymes Modulated Glycans during Infection. To establish the definitive role 
of the infection-associated glycan-degrading enzymes, we tested the glycan degradation capacity of Salmonella 
enzymes determined during in vitro infection of Caco-2 cells with WT Salmonella, ΔmelA, ΔCHPNeu, 
ΔnanH, ΔmalS, and ΔglgX. It was shown that GHs impacting invasive infection would be the same or less 
than ΔinvA (Fig. 1B). Bacterial degradation of the Caco-2 glycans is required for invasion. Glycan profiles of 
Figure 3. Host responds to microbial glycan degradation by modifying its own glycan. (A) Analysis of 
host pathways involved during glycan degradation of Caco-2 cells following microbial association. Canonical 
pathways whose biological functions were influenced based on gene expression changes are shown (Fishers 
exact test). Upregulated molecules in each pathway are represented as a percentage of the total canonical 
pathway membership. (B–E) Networks display interactions between genes involved in mannose, fucose 
and Neu5Ac ([D] sialidases and [E] sialyltransferases) metabolism, respectively, in Caco-2 cells treated for 
60 minutes with Salmonella LT2. ST3GAL family sialyltransferases catalyzed the addition of Neu5Ac to a 
terminal galactose of glycoconjugates in an α -2,3 linkage. The sialyltransferases in ST6GAL family transferred 
alpha-2,6 linking Neu5Ac to galactose residues of N-glycans. The ST6GALNAc family sialyltransferases added 
Neu5Ac to terminal N-acetylgalactosamine residues of glycoproteins and glycolipids, in an α -2,6 linkage. Lastly, 
the ST8Sia family catalyzes the transfer of Neu5Ac in an alpha-2,8 linkage to other Neu5Ac residue present 
in N- or O-glycans of Neural cells. Caco-2 up-regulation of enzymes in both gene networks is indicative of 
microbial induced changes in host glycan biosynthesis. Gene induction is represented as a log ratio (q < 0.05) 
and displayed in shades of red.
www.nature.com/scientificreports/
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the host cell after infection showed similar composition, all of which contained increased mannose content. 
During infection, the degrees of fucosylation and sialylation also shifted to have higher fucosylation and less 
sialylation (Fig. 4A). The host cell glycan composition was not expected to be altered during infection with 
ΔinvA since it contained all the glycan-degrading enzymes found in the WT. However, 11 different structures 
were observed compared to the WT, while the fucose and Neu5Ac content remained unchanged. The host gly-
can composition remained unchanged when infected with ΔmelA with six glycan differences compared to WT, 
which may explain the similar invasion phenotype as compared to the WT (Fig. 1B). Further examination of 
the glycans led to identification of specific structures that uniquely linked to Salmonella GHs, specifically siali-
dases and amylases, and regulated infection (Fig. 4B–E). While sialidases are required to initiate glycan degra-
dation we also observed that other glycan-degrading enzymes aid to complete the degradation of these glycans 
to invade. Glycans m/z = 2499.899 (Hex6HexNAc6Neu5Ac1), 2790.995 (Hex6HexNAc6Neu5Ac2), 3156.127 
(Hex7HexNAc7Neu5Ac2), 2979.099 (Hex5HexNAc7Fuc3Neu5Ac1), 2239.798 (Hex6HexNAc4Fuc1Neu5Ac1), and 
3026.089 (Hex6HexNAc5Fuc3Neu5Ac2) are sialylated glycans that were degraded during the infection with WT 
(Fig. 4C–E). Upon infection with mutant GHs, the most increase in relative abundance was seen during infection 
with ΔmalS, ΔmalS, ΔCHPNeu, ΔmalS, ΔglgX, and ΔmalS, respectively for each of the glycans, which may sug-
gest that these GHs targeted and degraded those glycans (Fig. 4C–E). Glycans m/z = 2167.777 (Hex7HexNAc5), 
1722.645 (Hex3HexNAc6), 2953.047 (Hex7HexNAc6Neu5Ac2), 2776.020 (Hex5HexNAc6Fuc3Neu5Ac1), and 
2556.946 (Hex4HexNAc5Fuc4Neu5Ac1) were accumulated (Fig. 4B–D), suggesting Salmonella induces the host to 
produce or increase the relative production of these glycans. Lastly, glycans m/z = 2688.004 (Hex5HexNAc7Fuc3) 
and 2483.904 (Hex5HexNAc6Fuc1Neu5Ac1) stayed at similar levels throughout the infection (Fig. 4B,D) suggest-
ing that Salmonella does not have the specificity to recognize these glycans to degrade. These results suggest that 
the GHs within a genome contribute to virulence. Perhaps GHs represent a new virulence mechanism that is con-
trolled by the host glycan structure and the gene content on the pathogen. This elucidates how glycan-degrading 
enzymes play an important role by altering the host glycan profiles during infection to gain access of the host 
epithelial cells. Also identifying exact glycans during infection will lead to identifying pathways that Salmonella 
uses to infect and invade the host.
Figure 4. Signature of glycan profiles and how each glycan-degrading enzyme modulates the glycans 
during infection. (A) Signature of glycan profiles during infection. There is an increase in abundances of high-
mannose and hybrid glycans. Also the glycans are switched from being highly sialylated to highly fucosylated 
(the degree of fucosylation increases and the degree of sialylation decreases); (B–E) Glycans that are highly 
regulated by Salmonella glycan-degrading enzymes during infection. The comparisons between CHPNeu and 
nanH (Sialidases) and malS and glgX (Amylases) are shown. LSD was used for statistical analysis. Error bars 
indicate SEM between 3 biological replications. Levels not connected with the same letter are significantly 
different. Statistical analysis was done within each structure.
www.nature.com/scientificreports/
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Discussion
Use of mucin and the glycocalyx by the microbiome is widely recognized6. Degrading the glycocalyx layer dis-
rupts the host’s defensive barrier that provides access to the epithelial cell surface and receptors for binding, col-
onization, and invasion. Because Salmonella infections represent a persistent and major health challenge around 
the world it is important to understand how to control Salmonella infections. This study examined the specific 
enzymes used to degrade the glycan.
The sequence of events leading to Salmonella infection in the gut epithelial cells has been elucidated for the 
T3SS22. However, prior to T3SS (invA) access to the membrane, Salmonella must overcome the protective gly-
cocalyx layer that coats the epithelium. In the gut Salmonella must first attach to and second degrade the host’s 
protective mucus and glycocalyx layer to gain access to the membrane and subsequently infect the underlying 
tissue. These results described here first identified that depletion of Neu5Ac from Caco-2 cells led to decreases 
in Salmonella association; therefore, this interaction lends insight into how Salmonella reaches the initial goals 
necessary to establish infection by using Neu5Ac as a potential receptor for adherence process.
In order to breach the glycocalyx layer, pathogens have evolved mechanisms to degrade the glycocalyx, which 
is common in many organisms6–10. Salmonella specifically is equipped with 48 enzymes from 21 families of gly-
cosyl hydrolases to overcome this barrier. This study found expression of specific glycan-degrading enzymes in 
Salmonella used to degrade the glycocalyx and alter the host glycans to mediate invasion, which were previously 
unrecognized genes important to the virulence mechanism.
While the microbe is degrading the host glycan, it is also very important to study the host response during 
degradation. Efforts were made to improve our understanding of glycan degradation and alteration compexity 
in its entirety via the use of high resolution mass spectrometry24 and gene expression profiling. The host genes 
that hydrolyze mannose, fucose, and Neu5Ac from the glycan; as well as sialyltransferases, were induced dur-
ing Salmonella infection (Fig. 3); supporting the hypothesis that new glycan structures were produced de novo 
(Fig. 2F) during infection. Hooper et al. and Bry et al. also found in vivo that the host produced new glycans con-
taining fucosylation in the ileum that is microbe induced via α 1,2-fucosyltransferase transcripts6,7. Refinement 
of the glycan by the Salmonella during infection was also observed (Fig. 4A). The shift to low Neu5Ac content is 
supported by these changes in sialidases and sialyltransferases (Fig. 3D,E, Supplementary Table S4). The accu-
mulation of fucosylated glycans is supported by the changes in host fucosidases and fucosyltransferases (Fig. 3C) 
after infection, as previously observed6,7. Pickard et al. also observed that rapid fucosylation appears to be a pro-
tective mechanism that utilizes the host’s resources during host-microbe interactions during pathogen induced 
stress25. These observations confirm the host response to glycan modification during Salmonella LT2 association 
and suggest a dynamic shift in the glycan is caused by Salmonella degradation coupled with the host remodeling 
to produce a glycan of different structures as the infection progresses. This could be a protective mechanism for 
the host during infection and suggests that the host is actively producing new glycans in response to Salmonella 
infection. The mechanism dictating this phenomenon has yet to be elucidated, which requires additional exper-
imentation to uncover the direct effect of Salmonella on host glycan metabolism. Glycan biosynthesis is signifi-
cantly affected by the disease states and distinct glycan structures could provide information about the specific 
pathologic states of disease23. The host constantly remodels its glycans without altering its intrinsic function, 
which alters microbiome association3 and modulates host immune surveillance methods26. The host may alters 
its glycan composition on their cell surfaces to eliminate the expression of a terminal glycan structures in order 
to limit pathogen binding. The host may discard non-critical glycans to allow its survival3. The loss of a particular 
glycan may involve inactivation of one or more genes involved in glycan biosynthesis27 and can prevent recogni-
tion by pathogens using structure as a receptor. In an effort to alter its glycans to evade pathogens, the host may 
create new glycan structures either by synthesis or modification.
By combining microbial genomics, glycan profiling, and infection analyses, this study provides unprecedented 
molecular details for the role of Salmonella GHs’ during infection of Caco-2 cells. Alterations in the degree of 
branching, changes in the amount, linkage, and degrees of sialylation and fucosylation in N-glycans have been 
reported as a consequence of diseases28,29, but this is the first report to describe how Salmonella Typhimurium 
degraded the glycans that resulted in an infection. Deleting GHs used for glycan degradation resulted in invasion 
magnitude equal to those associated with T3SS in Salmonella, suggesting that these enzymes may be as important 
as secretion systems. Defining the virulence characteristics and diversity of GHs in Salmonella can provide new 
insights into the importance of glycan structures during host-pathogen interactions. This study further expands 
our understanding of the infection characteristics and may lead to the host response in glycan modification as 
mutualistic events between the host production and pathogen degradation. Some of the more encouraging pros-
pects of this research are the potential for new treatments for gastroenteritis caused by Salmonella. This work may 
provide the basis of novel strategies to control enteric infections by targeting glycocalyx-degrading enzymes. The 
complexity of the pan-genome of Salmonella, as well as the multiple methods of infection used by Salmonella30,31 
demands the use of multi-omics to define innovative targets to control infection. Use of antibiotics alone is not 
meeting the needs to control this organism and often leads to increased susceptibility to other pathogens32. Use 
of glycan degradation will preempt Salmonella from gaining access of the membrane – a novel method to control 
infection that may be of use in multiple pathogens in the gut and other epithelial surfaces.
Methods
Cell Culture. All cell in vitro experiments were done using colonic epithelial cells (Caco-2; ATCC HTB-37) 
as described previous33–37. Detailed description of the cell growth conditions is available in Supplementary 
Information.
Bacterial Strains and Growth Conditions. Salmonella enterica subsp. enterica serovar Typhimurium 
strain LT2 (ATCC 700720; Salmonella WT) and the deletion mutants made in this study were used. All isolates 
www.nature.com/scientificreports/
8Scientific RepoRts | 6:29525 | DOI: 10.1038/srep29525
were grown in LB (Difco, BD) at 37 °C with shaking at 220 rpm for 14–16 hours before use. Each biological repli-
cate was done with a new vial of frozen stock after thawing and growth twice as described above.
Gene Deletion. Bacterial gene deletions were done as described by Datsenko and Wanner20. Detailed 
description of gene deletions is available in Supplementary Information.
Genomic sequencing and comparison. Each isolate was sequenced as described by Ludeke et al.38 as 
defined by the methods of the 100 K Pathogen Genome Sequencing Project39–47. Abyss 1.5.2 was used to assemble 
the paired end reads using k = 6448. Prokka was used for annotation49. Each genome was compared to the wild 
type by determining the genome distance using Genome-to-Genome Distance Calculator (GGDC) (http://ggdc.
dsmz.de/distcalc2.php)50,51. Whole genome comparisons were done using Mauve under Progressive Mauve as 
described by Darling et al.52,53. Contigs were reordered using the reorder contigs option in Mauve with default 
parameters using Salmonella Typhimurium LT2 ATCC 700720 (accession number AE006468) as the reference 
genome. All raw genome sequences generated in this study are available in the NCBI SRA as part of the 100 K 
Pathogen Genome Project Bioproject Accession PRJNA186441. Accession numbers are listed in Table S5. Single 
gene analyses were done by extracting sequences from each genome and using MUSCLE through Geneious 
version 6.1.8 to align sequences54,55.
Bacterial Association Measurements. Bacterial association was determined using a modified gentam-
ycin protection assay56,57 after adding each Salmonella treatment in a 96-well plate containing an MOI of 1:1000. 
The assay was done after incubation for 60 min at 37 °C with 5% CO2. Adhered bacteria were measured after the 
cell culture medium was aspirated and the host/microbe cell mixture was washed once with 200 μ l of 1X PBS 
buffer (pH 7). The host and associated microbes were lysed using 50 μ l of commercial Warnex lysis buffer (AES 
Chemunex) for use in qPCR assays to determine the absolute amount of host and bacteria57. All assays were done 
in three biological replicates.
To calculate number of adhered bacteria, the mean of the number of invaded bacteria was subtracted from the 
mean of the total number of host associated bacteria. The error for adhered bacteria was propagated using equa-
tion (Δ Z)2 = (Δ A)2 + (Δ B)2 where Δ Z is the standard error of mean (SEM) for adhered bacteria, Δ A is SEM for 
total host associated bacteria and Δ B is SEM for invaded bacteria. One-way ANOVA with Tukey test was done to 
find significant differences across treatment’s and control’s group means.
Gene Expression during Infection. Samples were collected as previously described32,34,58,59. Briefly, Caco-2 
cells were cultured in T-75 flasks (BD) and were serum starved 24 h before infection. Respective bacterial treat-
ments with Salmonella WT and the deletion mutants, at MOI of 1000, were used to infect epithelial cells as 
described previously. All treatments were incubated at 37 °C with 5% CO2 for 60 min. 10 ml of TRIzol LS reagent 
(Invitrogen, Carlsbad, CA) was added to the cells and mixed with pipette followed by centrifugation at 7,200 × g 
for 5 min to pellet the host associated bacteria. TRIzol LS supernatant was stored in a clean tube and further pro-
cessed for RNA extraction from infected Caco-2 cells. The bacterial pellet was suspended in 2 ml of fresh TRIzol 
LS, gently mixed and further processed for RNA extraction from host associated bacteria. The experiment was 
done in two biological replicates.
Bacterial RNA extraction and gene expression. Sample preparation for gene expression profiling was performed 
with RNA isolation, which was done using TRIzol LS reagent (Invitrogen) as described previously32,34. Total RNA 
(10 μ g in 20 μ l) was reverse transcribed into cDNA with 6 μ g of random hexamers and 400 U of Superscriptase II 
(Invitrogen) according to the manufacturer’s protocol. The reaction mixture was cleaned by using the 
Qiaquick-PCR purification kit (Qiagen, Valencia, CA) according to the manufacturer’s instructions and as 
described previously34. The purified single-strand cDNA was eluted from the columns twice with a total of 100 μ l 
of nuclease free water (Ambion, Austin, TX). cDNA fragmentation was done using 0.6 U of DNaseI (Promega, 
Madison, WI) per μ g of cDNA, according to the instructions. The fragmented 1 μ g of cDNA was labeled using 2 μ l 
of GeneChip DNA Labeling reagent (Affymetrix, Santa Clara, CA) and 60 U of Terminal Transferase enzyme 
(New England Biolabs, Ipswich, MA). The samples were denatured prior to hybridization, at 98 °C for 10 min 
followed by snap cooling at 4 °C for 5 min.
Hybridization and normalization. Labeled cDNA was hybridized onto a custom made Affymetrix GeneChip 
designed against all the annotated coding sequences of Salmonella LT2 ATCC 700720 (Salmonella WT)32,34,60. The 
chips were hybridized and scanned at the Center for Integrated BioSystems (Utah State University, Logan, UT) 
as per manufacturer’s protocols. Raw data (.cel files) was background corrected, quantile normalized and sum-
marized using MS-RMA32,61. The resultant normalized Log2 transformed intensity matrix was used for further 
statistical analysis.
Caco-2 RNA extraction and gene expression. The TRIzol LS samples containing infected or non infected 
Caco-2 cells were frozen (Liquid N2) and thawed (70 °C) twice. To 750 μ l of TRIzol LS sample, 250 μ l of water 
was added. This was further processed for RNA extraction using manufacturer’s (TRIzol LS, Invitrogen) instruc-
tions. Synthesis of cDNA, biotin labeled cRNA, fragmentation and purification of cRNA were carried out using 
one-cycle cDNA synthesis kit (Affymetrix, Santa Clara, CA).
Host hybridization and normalization. Labeled and fragmented cRNA (10 μ g) was hybridized onto the 
Affymetrix HGU133Plus2 GeneChips as per manufacturer’s recommendations at the Center for Integrated 
BioSystems (Utah State University, Logan, UT). Raw data (.cel files) was background corrected; quantile normal-
ized and summarized using RMA. RMA normalized data was then filtered through the PANP algorithm to make 
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presence-absence calls for each probe set. Probe sets that were called present in at least one of the samples were 
included in further statistical analysis.
Statistical analysis for gene expression. Gene expression profiles for Salmonella WT alone and in the presence 
of the epithelial cells were obtained 60 min post infection. The data was analyzed as two class unpaired with T 
statistic, using Significance Analysis of Microarrays (SAM)62. All the genes were ranked based on the score from 
SAM output. This pre-ordered ranked gene list was then used in Gene Set Enrichment Analysis software (GSEA) 
to detect the coordinate changes in the expression of groups of functionally related genes, upon respective treat-
ments. The gene sets were defined based on the annotations from Comprehensive Microbial Resource (CMR), 
Cluster of Orthologous Groups of proteins (COGs), and Virulence Factors of pathogenic bacteria Data Base 
(VFDB).
Glycan Degradation. Differentiated Caco-2 cells in T-75 flasks were infected with Salmonella WT and its 
knockouts at MOI 1:1000 and incubated for 60 min at 37 °C, 5% CO2. Infection samples were washed three times 
with ice cold 1X PBS to remove non-adherent bacteria and cellular debris. Cells were scraped from the flask with 
cell scraper and were kept on ice until cell membrane extraction and N-glycan release as detailed in Supplemental 
Information online. N-glycans were enriched and analyzed using Agilent HPLC-Chip-QTOF MS (Agilent, CA) 
as detailed in the Supplementary Information. N-Glycans were identified by composition with a retrosynthetic 
library using accurate mass according to mass tolerance, retention times, and abundance information24 and fur-
ther verified by tandem MS (Supplementary Figure S6).
Ingenuity Pathway Analysis. QIAGEN’S Ingenuity Pathway Analysis (IPA, QIAGEN Redwood City, www.
qiagen.com/ingenuity) software was used to determine biological pathways associated with our gene expression 
data (Ingenuity Systems, http://www.ingenuity.com, IPA release version summer 2014) similar to He et al.33. 
Networks representing molecular interaction were constructed based on the IPA database. Determination of 
pathway associations was determined through IPA (Fisher’s exact test).
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